查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1941466

液態切片市場規模、佔有率和趨勢分析報告：按生物標記、技術、檢體類型、應用、臨床應用、最終用途、產品、地區和細分市場分類，預測期為2026-2033年

Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker, By Technology, By Sample Type, By Application, By Clinical Application, By End Use, By Product, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

液態切片市場概述

全球液態切片市場預計到 2025 年將價值 136 億美元，預計到 2033 年將達到 325.7 億美元。

預計從 2026 年到 2033 年，該產業將以 11.52% 的複合年成長率成長。該行業持續成長的原因包括癌症發病率的上升、癌症診斷技術的進步以及對微創癌症診斷方法的需求不斷成長。

此外，隨著多癌種早期檢測技術的日益普及和發展，對液態切片檢測方法和檢測技術的研究不斷深入，為整個市場帶來了成長機會。液態切片是一種用於檢測腫瘤相關基因突變的先進檢測技術，也可用於腫瘤分層和精準癌症治療。例如，2023年1月，Guardant Health公司的液態切片檢測產品Guardant 360 CDx獲得FDA核准，作為ESR1突變型乳癌的伴隨診斷試劑。近年來，推動液態切片應用的行業創新、進步和拓展正在促進市場發展。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關及輔助市場展望
  • 市場動態
  • 市場促進因素
    • 癌症發生率增加
    • 人口老化加劇
    • 技術進步
    • 人們越來越傾向於選擇非侵入性治療
  • 市場限制因素分析
    • 處方類重磅藥物專利到期
  • 商業環境分析
    • SWOT 分析（按因素分類：政治/法律法規、經濟、技術）
    • 波特五力分析

第4章 依檢體類型進行業務分析

  • 液態切片市場：按檢體類型分類的差異分析
  • 血
  • 其他

第5章 基於生物標記的業務分析

  • 液態切片市場：按生物標記分類的差異分析
  • 循環性腫瘤細胞（CTCs）
  • 循環核酸
  • 外泌體/微囊泡
  • 其他

第6章：依技術進行業務分析

  • 液態切片市場：技術變革分析
  • 多基因平行分析（NGS）
  • 單基因分析（PCR微陣列）

第7章 應用業務分析

  • 液態切片市場：按應用領域分析變化
  • 癌症
  • 生殖健康
  • 其他

第8章：依最終用途進行業務分析

  • 液態切片市場：按最終用途分類的差異分析
  • 醫院和研究機構
  • 專科診所
  • 學術和研究機構
  • 其他

第9章：臨床應用商業分析

  • 液態切片市場：按臨床應用分類的差異分析
  • 治療方案
  • 治療監測
  • 早期癌症篩檢
  • 復發監測
  • 其他

第10章 產品業務分析

  • 液態切片市場：按產品分類的波動分析
  • 裝置
  • 耗材試劑盒和試劑
  • 軟體和服務

第11章：區域商業分析

  • 2025年及2033年各地區液態切片市場佔有率
  • 北美洲
    • 2021-2033年北美液態切片市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2021-2033年歐洲液態切片市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2021-2033年亞太地區液態切片市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2021-2033年拉丁美洲液態切片市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2021-2033年中東和非洲液態切片市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第12章 競爭格局

  • 參與公司概況
  • 財務業績
  • 參與企業
    • 市場領導
    • 液態切片市場佔有率分析（2025 年）
    • 公司簡介
    • 策略規劃
Product Code: GVR-1-68038-105-4

Liquid Biopsy Market Summary

The global liquid biopsy market size was estimated at USD 13.60 billion in 2025 and is projected to reach USD 32.57 billion by 2033, growing at a CAGR of 11.52% from 2026 to 2033. The industry is witnessing growth due to factors such as the growing prevalence of cancer, technological advancements in cancer diagnostics, and rising preference for minimally invasive cancer diagnostics.

Moreover, ongoing research for the development of liquid biopsy assays and tests, aided by the rising adoption and development of multi-cancer early detection tests, is providing a major opportunity for the growth of the overall market. Liquid biopsy is an advanced testing technology for the detection of genetic alterations related tumor. It has also been utilized to stratify tumors and deliver precise cancer treatment. For instance, in January 2023, Guardant Health received FDA approval for Guardant360 CDx, its liquid biopsy assay as companion diagnostics for ESR1 mutant breast cancer diagnosis. These recent innovations, advancements, and expansions in the industry promoting the use of liquid biopsy are driving the market.

Global Liquid Biopsy Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global liquid biopsy market report based on sample type, biomarker, technology, application, end use, clinical application, product, and region:

  • Sample Type Outlook (Revenue, USD Billion, 2021 - 2033)
  • Blood Sample
  • Others
  • Biomarker Outlook (Revenue, USD Billion, 2021 - 2033)
  • Circulating Tumor Cells (CTCs)
  • Circulating Nucleic Acids
  • Exosomes/Microvesicles
  • Others
  • Technology Outlook (Revenue, USD Billion, 2021 - 2033)
  • Multi-gene parallel Analysis (NGS)
  • Single Gene Analysis (PCR Microarrays)
  • Application Outlook (Revenue, USD Billion, 2021 - 2033)
  • Cancer
    • Lung Cancer
    • Prostate Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Leukemia
    • Gastrointestinal Cancer
    • Others
  • Reproductive Health
    • Others
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospitals and Laboratories
  • Specialty Clinics
  • Academic and Research Centers
  • Others
  • Clinical Application Outlook (Revenue, USD Billion, 2021 - 2033)
  • Therapy Selection
  • Treatment Monitoring
  • Early Cancer Screening
  • Recurrence Monitoring
  • Others
  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Instruments
  • Consumables Kits and Reagents
  • Software and Services
  • Regional Outlook (Revenue, USD Billion, 2021- 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. OBJECTIVE - 1
    • 1.2.2. OBJECTIVE - 2
    • 1.2.3. OBJECTIVE - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. PURCHASED DATABASE
    • 1.4.2. GVR'S INTERNAL DATABASE
    • 1.4.3. SECONDARY SOURCES
    • 1.4.4. PRIMARY RESEARCH
  • 1.5. Information or Data Analysis
    • 1.5.1. DATA ANALYSIS MODELS
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. COMMODITY FLOW ANALYSIS
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Increasing prevalence of cancer
    • 3.4.2. Growing geriatric population
    • 3.4.3. Technological advancements
    • 3.4.4. Increasing preference for noninvasive treatment
  • 3.5. Market Restraint Analysis
    • 3.5.1. Patent expiry of blockbuster drugs prescribed
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Sample Type Business Analysis

  • 4.1. Liquid Biopsy Market: Type Movement Analysis
  • 4.2. Blood Sample
    • 4.2.1. Blood Sample Market, 2021 - 2033 (USD Million)
  • 4.3. Others
    • 4.3.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Biomarker Business Analysis

  • 5.1. Liquid Biopsy Market: Biomarker Movement Analysis
  • 5.2. Circulating Tumor Cells (CTCs)
    • 5.2.1. Circulating Tumor Cells (CTCs) Market, 2021 - 2033 (USD Million)
  • 5.3. Circulating Nucleic Acids
    • 5.3.1. Circulating Nucleic Acids Market, 2021 - 2033 (USD Million)
  • 5.4. Exosomes/Microvesicles
    • 5.4.1. Exosomes/Microvesicles Market, 2021 - 2033 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Technology Business Analysis

  • 6.1. Liquid Biopsy Market: Technology Movement Analysis
  • 6.2. Multi-gene-parallel Analysis (NGS)
    • 6.2.1. Multi-gene-parallel Analysis (NGS) Market, 2021 - 2033 (USD Million)
  • 6.3. Single Gene Analysis (PCR Microarrays)
    • 6.3.1. Single Gene Analysis (PCR Microarrays) Market, 2021 - 2033 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Liquid Biopsy Market: Application Movement Analysis
  • 7.2. Cancer
    • 7.2.1. Cancer Market, 2021 - 2033 (USD Million)
      • 7.2.1.1. Lung Cancer
        • 7.2.1.1.1. Lung Cancer Market, 2021 - 2033 (USD Million)
      • 7.2.1.2. Prostate Cancer
        • 7.2.1.2.1. Prostate Cancer Market, 2021 - 2033 (USD Million)
      • 7.2.1.3. Breast Cancer
        • 7.2.1.3.1. Breast Cancer Market, 2021 - 2033 (USD Million)
      • 7.2.1.4. Colorectal Cancer
        • 7.2.1.4.1. Colorectal Cancer Market, 2021 - 2033 (USD Million)
      • 7.2.1.5. Leukemia
        • 7.2.1.5.1. Leukemia Market, 2021 - 2033 (USD Million)
      • 7.2.1.6. Gastrointestinal Cancer
        • 7.2.1.6.1. Gastrointestinal Cancer Market, 2021 - 2033 (USD Million)
      • 7.2.1.7. Others
        • 7.2.1.7.1. Others Market, 2021 - 2033 (USD Million)
  • 7.3. Reproductive Health
    • 7.3.1. Reproductive Health Market, 2021 - 2033 (USD Million)
  • 7.4. Others
    • 7.4.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. End Use Business Analysis

  • 8.1. Liquid Biopsy Market: End-Use Movement Analysis
  • 8.2. Hospitals and Laboratories
    • 8.2.1. Hospitals and Laboratories Market, 2021 - 2033 (USD Million)
  • 8.3. Specialty Clinics
    • 8.3.1. Specialty Clinics Market, 2021 - 2033 (USD Million)
  • 8.4. Academic and Research Centers
    • 8.4.1. Academic and Research Centers Market, 2021 - 2033 (USD Million)
  • 8.5. Others
    • 8.5.1. Others Liquid Biopsy Market, 2021 - 2033 (USD Million)

Chapter 9. Clinical Application Business Analysis

  • 9.1. Liquid Biopsy Market: Clinical Application Movement Analysis
  • 9.2. Therapy Selection
    • 9.2.1. Therapy Selection Market, 2021 - 2033 (USD Million)
  • 9.3. Treatment Monitoring
    • 9.3.1. Treatment Monitoring Market, 2021 - 2033 (USD Million)
  • 9.4. Early Cancer Screening
    • 9.4.1. Early Cancer Screening Market, 2021 - 2033 (USD Million)
  • 9.5. Recurrence Monitoring
    • 9.5.1. Recurrence Monitoring Market, 2021 - 2033 (USD Million)
  • 9.6. Others
    • 9.6.1. Others Liquid Biopsy Market, 2021 - 2033 (USD Million)

Chapter 10. Product Business Analysis

  • 10.1. Liquid Biopsy Market: Product Movement Analysis
  • 10.2. Instruments
    • 10.2.1. Instruments Market, 2021 - 2033 (USD Million)
  • 10.3. Consumables Kits and Reagents
    • 10.3.1. Consumables Kits and Reagents Market, 2021 - 2033 (USD Million)
  • 10.4. Software and Services
    • 10.4.1. Software and Services Market, 2021 - 2033 (USD Million)

Chapter 11. Regional Business Analysis

  • 11.1. Liquid Biopsy Market Share By Region, 2025 & 2033
  • 11.2. North America
    • 11.2.1. North America Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.2.2. U.S.
      • 11.2.2.1. Key Country Dynamics
      • 11.2.2.2. Target Disease Prevalence
      • 11.2.2.3. Competitive Scenario
      • 11.2.2.4. Regulatory Framework
      • 11.2.2.5. Reimbursement Scenario
      • 11.2.2.6. U.S. Liquid biopsy market, 2021 - 2033 (USD MILLION)
    • 11.2.3. Canada
      • 11.2.3.1. Key Country Dynamics
      • 11.2.3.2. Target Disease Prevalence
      • 11.2.3.3. Competitive Scenario
      • 11.2.3.4. Regulatory Framework
      • 11.2.3.5. Reimbursement Scenario
      • 11.2.3.6. Canada Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.2.4. Mexico
      • 11.2.4.1. Key Country Dynamics
      • 11.2.4.2. Target Disease Prevalence
      • 11.2.4.3. Competitive Scenario
      • 11.2.4.4. Regulatory Framework
      • 11.2.4.5. Reimbursement Scenario
      • 11.2.4.6. Mexico Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.3. Europe
    • 11.3.1. Europe Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.3.2. Germany
      • 11.3.2.1. Key Country Dynamics
      • 11.3.2.2. Target Disease Prevalence
      • 11.3.2.3. Competitive Scenario
      • 11.3.2.4. Regulatory Framework
      • 11.3.2.5. Reimbursement Scenario
      • 11.3.2.6. Germany Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.3.3. UK
      • 11.3.3.1. Key Country Dynamics
      • 11.3.3.2. Target Disease Prevalence
      • 11.3.3.3. Competitive Scenario
      • 11.3.3.4. Regulatory Framework
      • 11.3.3.5. Reimbursement Scenario
      • 11.3.3.6. UK Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.3.4. France
      • 11.3.4.1. Key Country Dynamics
      • 11.3.4.2. Target Disease Prevalence
      • 11.3.4.3. Competitive Scenario
      • 11.3.4.4. Regulatory Framework
      • 11.3.4.5. Reimbursement Scenario
      • 11.3.4.6. France Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.3.5. Italy
      • 11.3.5.1. Key Country Dynamics
      • 11.3.5.2. Target Disease Prevalence
      • 11.3.5.3. Competitive Scenario
      • 11.3.5.4. Regulatory Framework
      • 11.3.5.5. Reimbursement Scenario
      • 11.3.5.6. Italy Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.3.6. Spain
      • 11.3.6.1. Key Country Dynamics
      • 11.3.6.2. Target Disease Prevalence
      • 11.3.6.3. Competitive Scenario
      • 11.3.6.4. Regulatory Framework
      • 11.3.6.5. Reimbursement Scenario
      • 11.3.6.6. Spain Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.3.7. Denmark
      • 11.3.7.1. Key Country Dynamics
      • 11.3.7.2. Target Disease Prevalence
      • 11.3.7.3. Competitive Scenario
      • 11.3.7.4. Regulatory Framework
      • 11.3.7.5. Reimbursement Scenario
      • 11.3.7.6. Denmark Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.3.8. Sweden
      • 11.3.8.1. Key Country Dynamics
      • 11.3.8.2. Target Disease Prevalence
      • 11.3.8.3. Competitive Scenario
      • 11.3.8.4. Regulatory Framework
      • 11.3.8.5. Reimbursement Scenario
      • 11.3.8.6. Sweden Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.3.9. Norway
      • 11.3.9.1. Key Country Dynamics
      • 11.3.9.2. Target Disease Prevalence
      • 11.3.9.3. Competitive Scenario
      • 11.3.9.4. Regulatory Framework
      • 11.3.9.5. Reimbursement Scenario
      • 11.3.9.6. Norway Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.4. Asia Pacific
    • 11.4.1. Asia Pacific Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.4.2. Japan
      • 11.4.2.1. Key Country Dynamics
      • 11.4.2.2. Target Disease Prevalence
      • 11.4.2.3. Competitive Scenario
      • 11.4.2.4. Regulatory Framework
      • 11.4.2.5. Reimbursement Scenario
      • 11.4.2.6. Japan Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.4.3. China
      • 11.4.3.1. Key Country Dynamics
      • 11.4.3.2. Target Disease Prevalence
      • 11.4.3.3. Competitive Scenario
      • 11.4.3.4. Regulatory Framework
      • 11.4.3.5. Reimbursement Scenario
      • 11.4.3.6. China Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.4.4. India
      • 11.4.4.1. Key Country Dynamics
      • 11.4.4.2. Target Disease Prevalence
      • 11.4.4.3. Competitive Scenario
      • 11.4.4.4. Regulatory Framework
      • 11.4.4.5. Reimbursement Scenario
      • 11.4.4.6. India Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.4.5. South Korea
      • 11.4.5.1. Key Country Dynamics
      • 11.4.5.2. Target Disease Prevalence
      • 11.4.5.3. Competitive Scenario
      • 11.4.5.4. Regulatory Framework
      • 11.4.5.5. Reimbursement Scenario
      • 11.4.5.6. South Korea Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.4.6. Australia
      • 11.4.6.1. Key Country Dynamics
      • 11.4.6.2. Target Disease Prevalence
      • 11.4.6.3. Competitive Scenario
      • 11.4.6.4. Regulatory Framework
      • 11.4.6.5. Reimbursement Scenario
      • 11.4.6.6. Australia Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.4.7. Thailand
      • 11.4.7.1. Key Country Dynamics
      • 11.4.7.2. Target Disease Prevalence
      • 11.4.7.3. Competitive Scenario
      • 11.4.7.4. Regulatory Framework
      • 11.4.7.5. Reimbursement Scenario
      • 11.4.7.6. Thailand Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.5. Latin America
    • 11.5.1. Latin America Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.5.2. Brazil
      • 11.5.2.1. Key Country Dynamics
      • 11.5.2.2. Target Disease Prevalence
      • 11.5.2.3. Competitive Scenario
      • 11.5.2.4. Regulatory Framework
      • 11.5.2.5. Reimbursement Scenario
      • 11.5.2.6. Brazil Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.5.3. Argentina
      • 11.5.3.1. Key Country Dynamics
      • 11.5.3.2. Target Disease Prevalence
      • 11.5.3.3. Competitive Scenario
      • 11.5.3.4. Regulatory Framework
      • 11.5.3.5. Reimbursement Scenario
      • 11.5.3.6. Argentina Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Middle East and Africa Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.6.2. South Africa
      • 11.6.2.1. Key Country Dynamics
      • 11.6.2.2. Target Disease Prevalence
      • 11.6.2.3. Competitive Scenario
      • 11.6.2.4. Regulatory Framework
      • 11.6.2.5. Reimbursement Scenario
      • 11.6.2.6. South Africa Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.6.3. Saudi Arabia
      • 11.6.3.1. Key Country Dynamics
      • 11.6.3.2. Target Disease Prevalence
      • 11.6.3.3. Competitive Scenario
      • 11.6.3.4. Regulatory Framework
      • 11.6.3.5. Reimbursement Scenario
      • 11.6.3.6. Saudi Arabia Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.6.4. UAE
      • 11.6.4.1. Key Country Dynamics
      • 11.6.4.2. Target Disease Prevalence
      • 11.6.4.3. Competitive Scenario
      • 11.6.4.4. Regulatory Framework
      • 11.6.4.5. Reimbursement Scenario
      • 11.6.4.6. UAE Liquid biopsy market, 2021 - 2033 (USD Million)
    • 11.6.5. Kuwait
      • 11.6.5.1. Key Country Dynamics
      • 11.6.5.2. Target Disease Prevalence
      • 11.6.5.3. Competitive Scenario
      • 11.6.5.4. Regulatory Framework
      • 11.6.5.5. Reimbursement Scenario
      • 11.6.5.6. Kuwait Liquid biopsy market, 2021 - 2033 (USD Million)

Chapter 12. Competitive Landscape

  • 12.1. Participant's overview
  • 12.2. Financial performance
  • 12.3. Participant categorization
    • 12.3.1. Market Leaders
    • 12.3.2. Liquid Biopsy Market Share Analysis, 2025
    • 12.3.3. Company Profiles
      • 12.3.3.1. ANGLE plc
        • 12.3.3.1.1. Company Overview
        • 12.3.3.1.2. Financial Performance
        • 12.3.3.1.3. Product Benchmarking
        • 12.3.3.1.4. Strategic Initiatives
      • 12.3.3.2. Oncimmune Holdings PLC
        • 12.3.3.2.1. Company Overview
        • 12.3.3.2.2. Financial Performance
        • 12.3.3.2.3. Product Benchmarking
        • 12.3.3.2.4. Strategic Initiatives
      • 12.3.3.3. Guardant Health
        • 12.3.3.3.1. Company Overview
        • 12.3.3.3.2. Financial Performance
        • 12.3.3.3.3. Product Benchmarking
        • 12.3.3.3.4. Strategic Initiatives
      • 12.3.3.4. Myriad Genetics, Inc.
        • 12.3.3.4.1. Company Overview
        • 12.3.3.4.2. Financial Performance
        • 12.3.3.4.3. Product Benchmarking
        • 12.3.3.4.4. Strategic Initiatives
      • 12.3.3.5. Biocept, Inc.
        • 12.3.3.5.1. Company Overview
        • 12.3.3.5.2. Financial Performance
        • 12.3.3.5.3. Product Benchmarking
        • 12.3.3.5.4. Strategic Initiatives
      • 12.3.3.6. Lucence Health Inc.
        • 12.3.3.6.1. Company Overview
        • 12.3.3.6.2. Financial Performance
        • 12.3.3.6.3. Product Benchmarking
        • 12.3.3.6.4. Strategic Initiatives
      • 12.3.3.7. Freenome Holdings, Inc.
        • 12.3.3.7.1. Company Overview
        • 12.3.3.7.2. Financial Performance
        • 12.3.3.7.3. Product Benchmarking
        • 12.3.3.7.4. Strategic Initiatives
      • 12.3.3.8. F. Hoffmann-La Roche Ltd.
        • 12.3.3.8.1. Company Overview
        • 12.3.3.8.2. Financial Performance
        • 12.3.3.8.3. Product Benchmarking
        • 12.3.3.8.4. Strategic Initiatives
      • 12.3.3.9. QIAGEN
        • 12.3.3.9.1. Company Overview
        • 12.3.3.9.2. Financial Performance
        • 12.3.3.9.3. Product Benchmarking
        • 12.3.3.9.4. Strategic Initiatives
      • 12.3.3.10. Illumina, Inc.
        • 12.3.3.10.1. Company Overview
        • 12.3.3.10.2. Financial Performance
        • 12.3.3.10.3. Product Benchmarking
        • 12.3.3.10.4. Strategic Initiatives
      • 12.3.3.11. Thermo Fisher Scientific, Inc.
        • 12.3.3.11.1. Company Overview
        • 12.3.3.11.2. Financial Performance
        • 12.3.3.11.3. Product Benchmarking
        • 12.3.3.11.4. Strategic Initiatives
      • 12.3.3.12. Epigenomics AG
        • 12.3.3.12.1. Company Overview
        • 12.3.3.12.2. Financial Performance
        • 12.3.3.12.3. Product Benchmarking
        • 12.3.3.12.4. Strategic Initiatives
    • 12.3.4. Strategy Mapping
      • 12.3.4.1. Expansion
      • 12.3.4.2. Acquisition
      • 12.3.4.3. Collaborations
      • 12.3.4.4. Disease Type/Drug Class Launch
      • 12.3.4.5. Partnerships
      • 12.3.4.6. Others

List of Tables

  • Table 1 List of Tables
  • Table 2 Global Liquid Biopsy Market, By Region, 2021 - 2033 (USD Million)
  • Table 3 Global Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 4 Global Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 5 Global Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 6 Global Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 7 Global Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 Global Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 9 Global Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 10 North America Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
  • Table 11 North America Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 12 North America Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 13 North America Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 14 North America Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 15 North America Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 16 North America Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 17 North America Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 18 U.S. Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 19 U.S. Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 20 U.S. Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 21 U.S. Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 22 U.S. Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 23 U.S. Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 24 U.S. Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 25 Canada Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 26 Canada Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 27 Canada Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 28 Canada Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 Canada Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 Canada Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 31 Canada Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 32 Mexico Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 33 Mexico Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 34 Mexico Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 35 Mexico Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 36 Mexico Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 37 Mexico Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 38 Mexico Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 39 Europe Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
  • Table 40 Europe Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 41 Europe Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 42 Europe Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 43 Europe Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 44 Europe Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 45 Europe Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 46 Europe Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 UK Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 48 UK Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 49 UK Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 50 UK Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 51 UK Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 52 UK Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 53 UK Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 54 Germany Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 55 Germany Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 56 Germany Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 57 Germany Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 58 Germany Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 59 Germany Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 60 Germany Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 61 France Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 62 France Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 63 France Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 64 France Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 65 France Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 66 France Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 67 France Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 68 Italy Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 69 Italy Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 70 Italy Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 71 Italy Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 72 Italy Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 73 Italy Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 74 Italy Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 75 Spain Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 76 Spain Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 77 Spain Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 78 Spain Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 79 Spain Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 80 Spain Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 81 Spain Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 82 Denmark Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 83 Denmark Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 84 Denmark Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 85 Denmark Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 86 Denmark Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 Denmark Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 88 Denmark Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 89 Sweden Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 90 Sweden Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 91 Sweden Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 92 Sweden Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 93 Sweden Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 94 Sweden Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 95 Sweden Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 96 Norway Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 97 Norway Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 98 Norway Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 99 Norway Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 100 Norway Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 101 Norway Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 102 Norway Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 103 Asia Pacific Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
  • Table 104 Asia Pacific Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 105 Asia Pacific Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 106 Asia Pacific Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 107 Asia Pacific Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 108 Asia Pacific Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 Asia Pacific Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 110 Asia Pacific Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 111 Japan Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 112 Japan Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 113 Japan Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 114 Japan Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 115 Japan Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 116 Japan Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 117 Japan Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 118 China Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 119 China Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 120 China Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 121 China Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 122 China Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 123 China Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 124 China Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 125 India Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 126 India Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 127 India Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 128 India Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 129 India Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 130 India Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 131 India Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 132 Australia Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 133 Australia Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 134 Australia Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 135 Australia Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 136 Australia Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 137 Australia Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 138 Australia Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 139 South Korea Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 140 South Korea Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 141 South Korea Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 142 South Korea Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 143 South Korea Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 144 South Korea Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 145 South Korea Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 146 Thailand Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 147 Thailand Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 148 Thailand Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 149 Thailand Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 150 Thailand Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 151 Thailand Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 152 Thailand Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 153 Latin America Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
  • Table 154 Latin America Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 155 Latin America Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 156 Latin America Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 157 Latin America Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 158 Latin America Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 159 Latin America Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 160 Latin America Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 161 Brazil Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 162 Brazil Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 163 Brazil Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 164 Brazil Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 165 Brazil Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 166 Brazil Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 167 Brazil Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 168 Argentina Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 169 Argentina Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 170 Argentina Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 171 Argentina Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 172 Argentina Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 173 Argentina Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 174 Argentina Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 175 Middle East & Africa Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
  • Table 176 Middle East & Africa Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 177 Middle East & Africa Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 178 Middle East & Africa Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 179 Middle East & Africa Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 180 Middle East & Africa Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 181 Middle East & Africa Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 182 Middle East & Africa Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 183 South Africa Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 184 South Africa Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 185 South Africa Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 186 South Africa Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 187 South Africa Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 188 South Africa Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 189 South Africa Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 190 Saudi Arabia Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 191 Saudi Arabia Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 192 Saudi Arabia Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 193 Saudi Arabia Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 194 Saudi Arabia Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 195 Saudi Arabia Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 196 Saudi Arabia Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 197 UAE Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 198 UAE Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 199 UAE Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 200 UAE Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 201 UAE Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 202 UAE Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 203 UAE Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
  • Table 204 Kuwait Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
  • Table 205 Kuwait Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
  • Table 206 Kuwait Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
  • Table 207 Kuwait Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
  • Table 208 Kuwait Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
  • Table 209 Kuwait Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
  • Table 210 Kuwait Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Liquid biopsy market segmentation
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 Market challenge relevance analysis (Current & future impact)
  • Fig. 11 Penetration & growth prospect mapping
  • Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration vs growth prospect mapping
  • Fig. 15 Liquid biopsy market: Sample Type movement analysis
  • Fig. 16 Blood sample liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 17 Others liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 18 Liquid biopsy market: Biomarker movement analysis
  • Fig. 19 Circulating Tumor Cells (CTCs) liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 20 Circulating Nucleic Acids liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 21 Exosomes/Microvesicles liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 22 Others liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 23 Liquid biopsy market: Technology movement analysis
  • Fig. 24 Multi-gene-parallel analysis (NGS) liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 25 Single gene analysis (PCR Microarrays) liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 26 Liquid biopsy market: Application movement analysis
  • Fig. 27 Cancer liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 28 Lung cancer liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 29 Prostate cancer liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 30 Breast cancer liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 31 Colorectal cancer liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 32 Leukemia liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 33 Gastrointestinal cancer liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 34 Others liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 35 Reproductive Health liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 36 Others liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 37 Liquid biopsy market: End Use movement analysis
  • Fig. 38 Hospitals and Laboratories liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 39 Specialty clinics liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 40 Academic and research centers liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 41 Others liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 42 Liquid biopsy market: Clinical application movement analysis
  • Fig. 43 Therapy selection liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 44 Treatment monitoring liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 45 Early cancer screening liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 46 Recurrence monitoring liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 47 Others liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 48 Liquid biopsy market: Product movement analysis
  • Fig. 49 Instruments liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 50 Consumables kits and reagents liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 51 Software and Services liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 Regional outlook, 2021 & 2033
  • Fig. 54 North America liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 55 U.S. liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 56 Canada liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 57 Mexico liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 58 Europe liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 59 UK liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 60 Germany liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 61 Italy liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 62 Spain liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 63 France liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 64 Denmark liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 65 Sweden liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 66 Norway liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 67 Asia Pacific liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 68 Japan liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 69 China liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 70 India liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 71 Australia liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 72 South Korea liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 73 Thailand liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 74 Latin America liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 75 Brazil liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 76 Argentina liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 77 Middle East and Africa liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 78 South Africa liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 79 Saudi Arabia liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 80 UAE liquid biopsy market, 2021 - 2033 (USD Million)
  • Fig. 81 Kuwait liquid biopsy market, 2021 - 2033 (USD Million)